In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Q: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Comprehensive TB Elimination Act of
2018''.

SEC. 2. NATIONAL STRATEGY FOR COMBATING AND ELIMINATING TUBERCULOSIS.

(a) In General.--Section 317E of the Public Health Service Act (42
U.S.C. 247b-6) is amended--
(1) in subsection (a)--
(A) by striking ''The Secretary'' and inserting the
following:
''(1) Grants.--The Secretary''; and
(B) by adding at the end the following:
''(2) Priority.--In making grants under this subsection,
the Secretary may give priority to awarding grants to State
health departments proposing to focus on the prevention,
control, and elimination of tuberculosis in high-risk
populations, including foreign-born, homeless, incarcerated,
HIV-tuberculosis coinfected, and medically underserved
populations.'';
(2) in subsection (b)--
(A) in paragraph (3)--
(i) in subparagraph (C), by redesignating
clauses (i) and (ii) as subclauses (I) and
(II), respectively, and adjusting the margins
accordingly; and
(ii) by redesignating subparagraphs (A)
through (F) as clauses (i) through (vi),
respectively, and adjusting the margins
accordingly;
(B) by redesignating paragraphs (1) through (8) as
subparagraphs (A) through (H), respectively, and
adjusting the margins accordingly;
(C) in the matter preceding subparagraph (A), as so
redesignated, by striking ''With respect to'' and
inserting the following:
''(1) In general.--With respect to''; and
(D) by striking subparagraph (B), as so
redesignated, and inserting the following:
''(B) Research, investigations, experiments,
demonstrations, and studies in the health sciences that
are related to--
''(i) the development of new therapeutics,
including vaccines and antimicrobial drugs, to
prevent and treat tuberculosis;
''(ii) novel therapeutics for special
populations, including pediatric populations,
immunosuppressed individuals, and pregnant
women;
''(iii) the development or testing of
medical diagnostics to detect tuberculosis;
''(iv) public health interventions to
address the epidemiology, mechanisms, and
pathogenesis of tuberculosis, such as directly
observed therapy and non-pharmaceutical
intervention;
''(v) methods to enhance detection and
response to outbreaks of tuberculosis,
including multidrug resistant tuberculosis; and
''(vi) other relevant research areas.'';
(E) in subparagraph (C), as so redesignated--
(i) by redesignating clause (vi), as so
redesignated, as clause (vii);
(ii) in clause (v), as so redesignated, by
striking ''; and'' and inserting '';''; and
(iii) by inserting after clause (v), as so
redesignated, the following:
''(vi) the intensification of efforts to
prevent, detect, and treat latent tuberculosis;
and'';
(F) in subparagraph (D), as so redesignated, by
inserting before the period the following: '',
including public awareness campaigns and development of
educational, risk, and media communications.'';
(G) in subparagraph (F), as so redesignated, by
striking ''paragraphs (1) through (4)'' and inserting
''subparagraphs (A) through (D)''; and
(H) by adding at the end the following:
''(2) Selection.--In carrying out the activities described
in paragraph (1), the Secretary--
''(A) is encouraged to give priority to
programmatically relevant research so that new tools
can be utilized in public health practice; and
''(B) may seek input from the Biomedical Advanced
Research and Development Authority in identifying novel
candidates to utilize in the efforts under this
subsection to prevent, diagnose, and control
tuberculosis.'';
(3) by redesignating subsections (c) through (h) as
subsections (d) through (i), respectively;
(4) by inserting after subsection (b) the following--
''(c) Grants for Coordination of Programs and Services for
Prevention, Diagnosis, and Treatment.--
''(1) Grants.--The Secretary, acting through the
Administrator of the Health Resources and Services
Administration, may award grants to State and local governments
and Federally qualified health centers for coordinating the
programs and services of such States, governments, and centers
to ensure timely and appropriate prevention, risk-based
screening, diagnosis, and treatment of latent and active
tuberculosis.
''(2) Definition.--In this subsection, the term 'Federally
qualified health center' has the meaning given to such term in
section 1861(aa) of the Social Security Act.'';
(5) in subsections (d), (e), and (f), as so redesignated,
by striking ''(a) or (b)'' each place it appears and inserting
''(a), (b), or (c)'';
(6) in subsection (g)(4), as so redesignated, by adding at
the end the following:
''(C) Report to congress.--The Secretary is
encouraged to make the reports under subparagraph (A),
or other publications relevant to domestic tuberculosis
surveillance, publicly available on the Internet
website of the Centers for Disease Control and
Prevention and disseminate such information to
stakeholders.'';
(7) in subsection (h), as so redesignated--
(A) in paragraph (1)--
(i) by striking ''research into new tools
under subsection (b)(2)'' and inserting ''the
research, investigations, experiments,
demonstrations, and studies in health science
under subsection (b)(1)(B)''; and
(ii) by inserting ''ensuring access to the
products developed as a result of such
research, investigations, experiments,
demonstrations, and studies and'' after
''advice regarding''; and
(B) in paragraph (3)--
(i) by redesignating subparagraphs (D) and
(E) as subparagraphs (E) and (F), respectively;
and
(ii) by inserting after subparagraph (C)
the following:
''(D) members of the Biomedical Advanced Research
and Development Authority;''; and
(8) in subsection (i)(1)(A), as so redesignated, by
striking ''$200,000,000'' and all that follows through the
period and inserting ''$142,200,000 for fiscal year 2018,
$195,700,000 for fiscal year 2019, $225,000,000 for fiscal year
2020, $236,250,000 for fiscal year 2021, $248,062,500 for
fiscal year 2022, and $260,465,625 for fiscal year 2023.''.
(b) NIH Tuberculosis Activities.--Section 424C(b) of the Public
Health Service Act (42 U.S.C. 285b-7c(b)) is amended by striking
paragraph (1) and inserting the following:
''(1) enhancing basic, clinical, and operational research
on tuberculosis, including with respect to--
''(A) drug-resistant tuberculosis;
''(B) infection with tuberculosis and latency and
progression of tuberculosis; and
''(C) pediatric tuberculosis;''.

SEC. 3. GAO STUDY.

Not later than 2 years after the date of enactment of this Act, the
Comptroller General of the United States shall issue a report on the
coordination of efforts in the United States to--
(1) prevent, control, and eliminate tuberculosis; and
(2) implement the activities under section 317E of the
Public Health Service Act (42 U.S.C. 247b-6), as amended by
this Act, and the National Action Plan for Combating Multidrug-
Resistant Tuberculosis, issued in December 2015.
A:
Comprehensive TB Elimination Act of 2018 This bill amends the Public Health Service Act to reauthorize for FY2018-FY2023 and revise the tuberculosis (TB) prevention and treatment grant program administered by the Centers for Disease Control and Prevention. The Health Resources and Services Administration may also award grants to state and local governments and federally-qualified health centers for TB prevention and treatment efforts. Additionally, the Government Accountability Office must report on national TB prevention and treatment efforts.